Overall rank by patents
#25,833
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60P (VEHICLES ADAPTED FOR LOAD TRANSPORTATION OR TO TRANSPORT, TO CARRY, OR TO COMPRISE SPECIAL LOADS OR OBJECTS).
The verdict
B2B holds 10 US patents across 3 technology areas, rank #25,833 of 50,000 tracked assignees.
B2B Casuals, Inc. has been granted 10 US utility patents between 2015 and 2024, placing B2B Casuals, Inc. at rank #25,833 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.6 claims per patent with primary concentration in B60P (VEHICLES ADAPTED FOR LOAD TRANSPORTATION OR TO TRANSPORT, TO CARRY, OR TO COMPRISE SPECIAL LOADS OR OBJECTS). As a US Corporation, B2B Casuals, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, B2B sits between Axon Neuroscience SE (10 patents, rank #25,829) and Bauer Compressors, Inc. (10 patents, rank #25,837) - the closest US assignees by grant volume. The composite Innovation Score of 25.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 8 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. B2B Casuals, Inc.'s 6.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark B2B Casuals, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Axon Neuroscience SE
10 patents
Axus Technology, LLC
10 patents
Ayasdi, Inc.
10 patents
Aylus Networks, Inc.
10 patents
BACKSAVER INTERNATIONAL, INC.
10 patents
BAKER IDI HEART AND DIABETES INSTITUT HOLDINGS LTD.
10 patents
BALLAST MEDICAL INC.
10 patents
BAUER COMPRESSORS, INC.
10 patents
B2B Casuals, Inc.
10 patents
What this shows B2B holds 10 patents at rank #25,833, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
B2B's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 84% higher than 16% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 40.0% |
| 2016 | 4 | 40.0% |
| 2021 | 1 | 10.0% |
| 2024 | 1 | 10.0% |
Top 3 of 3 technology areas
Overall rank by patents
#25,833
Across all tracked assignees
25.0 out of 100
How to use this portfolio
B2B's 10 grants land it in the top 84% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.